
    
      The study will consist of a screening period in which subject eligibility will be determined.
      Approximately 50 subjects meeting the study entry criteria will be enrolled. Placement of the
      WRAPSODY stent graft will follow the procedure. Post study procedure subjects will have
      planned follow-up visits at 30 days, 3, 6 and 12months, and additional visits as referred by
      the subject's dialysis facility.

      The primary study safety endpoint will be the proportion of subjects without any localized or
      systemic safety events through 30 days that affect the access or venous outflow circuit and
      resulted in surgery, hospitalization, or death. Subjects will continue to be followed up to
      12 months for supplementary information.
    
  